Infineon Technologies AGBSD316SNH6327XTSA1MOSFETs

Trans MOSFET N-CH 30V 1.4A 6-Pin SOT-363 T/R Automotive AEC-Q101

Make an effective common gate amplifier using this BSD316SNH6327XTSA1 power MOSFET from Infineon Technologies. Its maximum power dissipation is 500 mW. In order to guarantee safe delivery and allow for quick mounting of this component after delivery, it will be enclosed in tape and reel packaging during shipment. This MOSFET transistor has an operating temperature range of -55 °C to 150 °C. This device utilizes optimos 2 technology. This N channel MOSFET transistor operates in enhancement mode.

Total In Stock: 36,903 parts

Regional Inventory: 27,903

    Total$0.04Price for 1

    27,903 In stock: Ships in 2 days

    • Service Fee  $7.00

      Ships in 2 days

      Ships from:
      United States of America
      Date Code:
      2245+
      Manufacturer Lead Time:
      8 weeks
      Minimum Of :
      1
      Maximum Of:
      2999
      Country Of origin:
      Austria
         
      • Price: $0.0390
      Spliced leader/trailer tape per EIA standards Leader tape:400mm=15.75'; Trail tape:160mm=6.3' more information
    • Ships in 2 days

      Ships from:
      United States of America
      Date Code:
      2245+
      Manufacturer Lead Time:
      8 weeks
      Country Of origin:
      Austria
      • In Stock: 903 parts
      • Price: $0.0390
    • (3000)

      Ships in 2 days

      Increment:
      3000
      Ships from:
      United States of America
      Date Code:
      2330+
      Manufacturer Lead Time:
      8 weeks
      Country Of origin:
      Austria
      • In Stock: 27,000 parts
      • Price: $0.0097
    • (3000)

      Ships in 4 days

      Ships from:
      Netherlands
      Date Code:
      2446+
      Manufacturer Lead Time:
      8 weeks
      Country Of origin:
      China
      • In Stock: 9,000 parts
      • Price: $0.0522

    Design AI-powered medical devices

    Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.